Wego’s interventional equipment subsidiary has secured a nine-digit dollar amount from a host of investors including China Construction Bank’s CCB International vehicle.

Shandong Wego Interventional Medical Technology, a subsidiary of China-based medical device manufacturer Wego, secured billions of yuan (RMB1bn = $157m) in series A funding yesterday.

XJ Capital, an investment manager sponsored by investment banking firm Citic Group, invested $66m to lead the round, which included financial services firm China Construction Bank’s CCB International unit, Haitong-Fortis Yangtze River Growth Equity Investment, China-Belgium Direct Equity Investment Fund and unnamed others.

Formed in 2013, Wego Interventional produces interventional equipment and consumables intended for…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Edison Fu

Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Email LinkedIn